Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H9I2NO3 |
Molecular Weight | 432.9816 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(O)=O
InChI
InChIKey=NYPYHUZRZVSYKL-ZETCQYMHSA-N
InChI=1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1
Molecular Formula | C9H9I2NO3 |
Molecular Weight | 432.9816 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Diiodotyrosine (DIT) is a regulatory ligand for thyroid peroxidase, enzyme, which is involved in the production of thyroxine (T4) and triiodothyronine (T3), the thyroid hormones. Diiodotyrosine was proposed to be a new marker of leukocyte phagocytic activity in sepsis and severe infections.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P07202|||Q8TCI9 Gene ID: 7173.0 Gene Symbol: TPO Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1149735 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2005222 |
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Enzymatic deiodination of diiodotyrosine; possible mediation by reduced flavin nucleotide. | 1969 Apr |
|
Inhibition of deiodination of diiodotyrosine in vivo; relation to catecholamine biosynthesis. | 1969 Mar 15 |
|
Free diiodotyrosine effects on protein iodination and thyroid hormone synthesis catalyzed by thyroid peroxidase. | 1975 Feb 21 |
|
Diiodotyrosine (DIT): a new marker of leukocyte phagocytic activity in sepsis and severe infections. | 1989 |
|
Elevated serum diiodotyrosine (DIT) in severe infections and sepsis: DIT, a possible new marker of leukocyte activity. | 1991 Apr |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1149735
Inhibition of thyroglobulin iodination catalyzed by thyroid peroxidase was observed when free diiodotyrosine concentration was higher than 5 muM. This inhibition was competitive, suggesting that free diiodotyrosine interacts with the substrate site(s) of thyroid peroxidase. Free diiodotyrosine also competively inhibited iodide peroxidation to I2. 2. Free diiodotyrosine, when incubated with thyroid peroxidase in the absence of iodide was recovered unmodified; in the presence of iodide an exchange reaction was observed between the iodine atoms present in the diiodotyrosine molecule and iodide present in the medium. Using 14C-labelled diiodotyrosine, 14C-labelled non-iodinated products were also observed, showing that deiodination occurred as a minor degradation pathway.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:27:54 GMT 2023
by
admin
on
Fri Dec 15 16:27:54 GMT 2023
|
Record UNII |
6L57Q44ZWW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QH03BX01
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
||
|
WHO-ATC |
H03BX01
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
||
|
DSLD |
3527 (Number of products:4)
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300-39-0
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
9305
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
57506
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
4143
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
206-092-0
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
6L57Q44ZWW
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
100000079224
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
3146
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
DIIODOTYROSINE
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
15768
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
m4480
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB13599MIG
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY | |||
|
DTXSID0048680
Created by
admin on Fri Dec 15 16:27:54 GMT 2023 , Edited by admin on Fri Dec 15 16:27:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
||
|
TRANSPORTER -> INHIBITOR |
Inhbiting gabapentin accumulation in the HEK-LAT1 cells
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|